4//SEC Filing
Webb David Ritchie 4
Accession 0001181431-12-055214
CIK 0000850261other
Filed
Oct 18, 8:00 PM ET
Accepted
Oct 19, 8:13 PM ET
Size
7.9 KB
Accession
0001181431-12-055214
Insider Transaction Report
Form 4
Webb David Ritchie
Director
Transactions
- Award
Non-qualified stock option
2012-10-17+450,000→ 450,000 totalExercise: $0.16Exp: 2022-10-17→ Common Stock (450,000 underlying) - Disposition to Issuer
Non-qualified stock option
2012-10-17−37,500→ 0 totalExercise: $0.14Exp: 2021-09-28→ Common Stock (37,500 underlying)
Footnotes (3)
- [F1]1/48 of the original number of shares subject to this option shall vest and become exercisable following each one-month period of service starting on September 6, 2012, subject to the reporting person's continued service on the issuer's board of directors on each such date.
- [F2]These options were surrendered to the issuer by the reporting person.
- [F3]1/4 of the original number of shares subject to this option vested on September 28, 2012 and 1/4 of the original number of shares subject to this option shall vest on each anniversary thereafter, subject to the reporting person's continued service to the issuer through each such vesting date.
Documents
Issuer
Sorrento Therapeutics, Inc.
CIK 0000850261
Entity typeother
Related Parties
1- filerCIK 0001557756
Filing Metadata
- Form type
- 4
- Filed
- Oct 18, 8:00 PM ET
- Accepted
- Oct 19, 8:13 PM ET
- Size
- 7.9 KB